International and Fortune 500 clients know who to turn to when facing complex patent litigation. As co-leader of Schiff Hardin’s Intellectual Property Group, Sailesh (Sal) K. Patel also co-chairs the firm’s Pharmaceuticals and Biologics Patent Litigation Team and serves on the firm’s executive committee. Sal is a seasoned trial attorney and has first-chaired more than 10 trials and appeals. He is passionate about implementing creative and scientifically sound arguments for his clients, which has resulted in legal precedent-setting cases.
Sal has served as lead counsel on numerous patent infringement litigation matters. With a background in chemical and biomedical engineering, he is familiar with the language of the pharmaceutical and life sciences industries. Defense against patent infringement requires subject matter experts; Sal is skilled at aligning the best experts to successfully defend his clients’ interests.
Sal is effective both in trials and in negotiating favorable settlements for his clients. There are many moving parts in patent litigation, and he is skilled at coordinating multiple parties, experts, and arguments into coherent and persuasive cases. In cases where there are multiple defendants, he represents his clients in a way that makes them stand out from the rest, leading to more favorable results. He also assists companies in Paragraph IV and biosimilars design strategies, helping his clients protect their scientific discoveries.
He has significant experience in preparing and prosecuting patent applications in a variety of technologies. Sal has represented clients in cases involving Hatch-Waxman litigation, biosimilars, wind and solar technology, medical devices, life science, food processing, automotive components, and software, among other sectors.
In addition to his legal practice, Sal also chairs the firm’s Diversity Committee.